High-Risk IgVH-Unmutated Chronic Lymphocytic Leukemia
EP. 1: Case Review: 62-Year-Old Man Diagnosed with CLL
Watch
EP. 2: IgVH and Other High-Risk Cytogenetic Risk Factors in CLL
EP. 3: Rationale for Frontline Ibrutinib +/- Rituximab in CLL
EP. 4: Embracing Newer Therapies in High-Risk CLL
